Healthequity, Inc S-3ASR, filed Sep 9, 2021
Healthequity, Inc. (HQY)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
UNDER
THE SECURITIES ACT OF 1933
| |
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
52-2383166
(I.R.S. Employer Identification Number)
|
|
Ste. 100
Draper, Utah 84020
(801) 727-1000
President and Chief Executive Officer
15 W. Scenic Pointe Dr.
Ste. 100
Draper, Utah 84020
(801) 727-1000
Matthew J. Haddad, Esq.
Jeffrey S. Hochman, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
(212) 728-8000
From time to time after this Registration Statement becomes effective.
| |
Large accelerated filer ☒
|
| |
Accelerated filer
☐
|
|
| |
Non-accelerated filer ☐
|
| |
Smaller reporting company
☐
|
|
| | | | |
Emerging growth company
☐
|
|
| | | ||||||||||||||||
|
Title of Each Class of Securities to Be Registered
|
| | |
Amount to Be
Registered |
| | |
Proposed Maximum
Offering Price per Unit |
| | |
Proposed Maximum
Aggregate Offering Price |
| | |
Amount of Registration
Fee |
|
| Securities to be sold by the Registrant: | | | | | | | | | | | | | | | | | |
|
Common stock, par value $0.0001 per share
|
| | |
(1)
|
| | |
(1)
|
| | |
(1)
|
| | |
(2)
|
|
|
Preferred stock, par value $0.0001 per share
|
| | |
(1)
|
| | |
(1)
|
| | |
(1)
|
| | |
(2)
|
|
|
Warrants
|
| | | | | | | | | | | | | | | | |
|
Debt securities
|
| | |
(1)
|
| | |
(1)
|
| | |
(1)
|
| | |
(2)
|
|
|
Units
|
| | | | | | | | | | | | | | | | |
| Securities to be sold by the Selling Stockholder: | | | | | | | | | | | | | | | | | |
|
Common stock, par value $0.0001 per share(3)
|
| | |
978,431
|
| | |
$65.46(3)
|
| | |
$13,690,698(3)
|
| | |
$1,494(3)(4)
|
|
Preferred Stock
Debt Securities
Warrants
Units
| | | | | | 4 | | | |
| | | | | | 4 | | | |
| | | | | | 4 | | | |
| | | | | | 5 | | | |
| | | | | | 5 | | | |
| | | | | | 12 | | | |
| | | | | | 13 | | | |
| | | | | | 15 | | | |
| | | | | | 15 | | | |
| | | | | | 15 | | | |
| | | | | | 16 | | |
|
Name
|
| |
Shares Beneficially Owned
Before the Offering |
| |
Number of
Shares Being Sold |
| |
Shares Beneficially
Owned After the Offering(1) |
| ||||||||||||||||||
| |
Number (#)
|
| |
Percent(2)
|
| |
Number (#)
|
| |
Percent(2)
|
| |||||||||||||||||
|
Stephen D. Neeleman, M.D.(3)
|
| | | | 978,431 | | | | | | 1.2% | | | | | | 978,431 | | | | | | — | | | |
*
|
|
| | | |
Amount to
be Paid |
| |||
|
SEC registration fee
|
| | | $ | 1,494(1)(2) | | |
|
Printing and engraving expenses
|
| | |
|
(2)
|
| |
|
Legal fees and expenses
|
| | |
|
(2)
|
| |
|
Trustee’s fees and expenses
|
| | |
|
(2)
|
| |
|
Accounting fees and expenses
|
| | |
|
(2)
|
| |
|
Transfer agent and registrar
|
| | |
|
(2)
|
| |
|
Miscellaneous
|
| | |
|
(2)
|
| |
|
TOTAL
|
| | |
|
(2)
|
| |
|
Exhibit
Number |
| | | | |
Incorporated by Reference
|
| |||||||||
| |
Exhibit Description
|
| |
Form
|
| |
Date
|
| |
Number
|
| |
Filed Herewith
|
| ||
|
1.1*
|
| | Form of Underwriting Agreement | | | | | | | | | | | | | |
|
3.1
|
| | | |
8-K
|
| |
7/6/2018
|
| |
001-36568
|
| | | | |
|
3.2
|
| | | |
8-K
|
| |
7/6/2018
|
| |
001-36568
|
| | | | |
|
4.1
|
| | | |
S-1/A
|
| |
7/16/2014
|
| |
333-196645
|
| | | | |
|
4.2
|
| | | |
S-3
|
| |
9/7/2018
|
| |
333-227231
|
| | | | |
|
4.3*
|
| | Form of Debt Security | | | | | | | | | | | | | |
|
4.4*
|
| | Form of Preferred Stock Certificate | | | | | | | | | | | | | |
|
4.5*
|
| | Form of Certificate of Designations | | | | | | | | | | | | | |
|
4.6*
|
| | Form of Warrant Agreement | | | | | | | | | | | | | |
|
4.7*
|
| | Form of Warrant Certificate | | | | | | | | | | | | | |
|
4.8*
|
| | Form of Unit Agreement | | | | | | | | | | | | | |
|
Exhibit
Number |
| | | | |
Incorporated by Reference
|
| |||||||||
| |
Exhibit Description
|
| |
Form
|
| |
Date
|
| |
Number
|
| |
Filed Herewith
|
| ||
|
5.1
|
| | | | | | | | | | | | |
X
|
| |
|
23.1
|
| | | | | | | | | | | | |
X
|
| |
|
23.2
|
| | | | | | | | | | | | |
X
|
| |
|
24.1
|
| | | | | | | | | | | | |
X
|
| |
|
25.1
|
| | Statement of Eligibility on Form T-1 of Wells Fargo Bank, National Association, under the Trust Indenture Act of 1939, as amended | | | | | | | | | | | |
X
|
|
President and Chief Executive Officer
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Robert Selander
Robert Selander
|
| |
Chairman of the Board, Director
|
| |
September 9, 2021
|
|
| |
/s/ Jon Kessler
Jon Kessler
|
| |
President, Chief Executive
Officer, and Director (Principal Executive Officer) |
| |
September 9, 2021
|
|
| |
/s/ Tyson Murdock
Tyson Murdock
|
| |
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
|
| |
September 9, 2021
|
|
| |
/s/ Frank Corvino
Frank Corvino
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s Adrian Dillon
Adrian Dillon
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s/ Evelyn Dilsaver
Evelyn Dilsaver
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s/ Debra McCowan
Debra McCowan
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s/ Stephen Neeleman, M.D.
Stephen Neeleman, M.D.
|
| |
Vice Chairman and Director
|
| |
September 9, 2021
|
|
| |
/s/ Stuart Parker
Stuart Parker
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s/ Ian Sacks
Ian Sacks
|
| |
Director
|
| |
September 9, 2021
|
|
| |
/s/ Gayle Wellborn
Gayle Wellborn
|
| |
Director
|
| |
September 9, 2021
|
|
Exhibit 5.1
|
787 Seventh Avenue |
September 9, 2021
HealthEquity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper, Utah 84020
Ladies and Gentlemen:
We have acted as counsel to HealthEquity, Inc., a Delaware corporation (the “Company”), in connection with the Company’s Registration Statement on Form S-3 to which this opinion is filed as an exhibit (the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), for the registration of: (A) the sale by the Company from time to time of (i) common stock, par value $0.0001 per share (“Common Stock”), of the Company, (ii) preferred stock, par value $0.0001 per share (“Preferred Stock”), of the Company, (iii) debt securities (the “Debt Securities”) of the Company, (iv) warrants to purchase Common Stock, warrants to purchase Preferred Stock and warrants to purchase Debt Securities (collectively, the “Warrants”), and (v) units of the Company comprised of any combination of Debt Securities, Common Stock, Preferred Stock, and Warrants (the “Units”); and (B) an aggregate of 978,431 shares of Common Stock to be sold from time to time by a certain selling stockholder of the Company (the “Selling Stockholder Shares”). The Debt Securities are to be issued under an indenture substantially in the form attached as an exhibit to the Registration Statement (the “Base Indenture”), as may be supplemented.
We have examined copies of the Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Incorporation”), the Amended and Restated Bylaws of the Company, the Base Indenture, the Registration Statement, the prospectus included in the Registration Statement (the “Prospectus”), relevant resolutions adopted by the Company’s Board of Directors (the “Board of Directors”), and other records and documents that we have deemed necessary for the purpose of this opinion.
We have also examined forms of the Debt Securities, the specimen Common Stock and are familiar with originals or copies, certified or otherwise identified to our satisfaction, of such other documents, corporate records, papers, statutes and authorities as we have deemed necessary to form a basis for the opinions hereinafter expressed.
In our examination, we have assumed the genuineness of all signatures and the conformity to original documents of all copies submitted to us. As to various questions of fact material to our opinion, we have relied on statements and certificates of officers and representatives of the Company and public officials.
New York Washington Houston Palo Alto San Francisco Chicago Paris London Frankfurt Brussels Milan Rome
HealthEquity, Inc.
September 9, 2021
Page 2
In connection with the opinions expressed below, we have assumed that, at or prior to the time of the delivery of any such security, (i) the Company shall have duly established the terms of such security and duly authorized the issuance and sale of such security and such authorization shall not have been modified or rescinded; (ii) such parties other than the Company shall have the power, corporate or other, to enter into and perform all obligations in accordance with the documents to be executed by such parties, and we have also assumed that upon the execution and delivery by such parties of such documents that such documents shall constitute valid and binding obligations of such parties; (iii) the Registration Statement shall be effective and such effectiveness shall not have been terminated or rescinded; and (iv) there shall not have occurred any change in law affecting the validity or enforceability of such security. We have also assumed that none of the terms of any security to be established subsequent to the date hereof, nor the issuance and delivery of such security, nor the compliance by the Company with the terms of such security will violate any applicable law or will result in a violation of any provision of any instrument or agreement then binding upon the Company, or any restriction imposed by any court or governmental body having jurisdiction over the Company.
Based on and subject to the foregoing and to the other qualifications and limitations set forth herein, we are of the opinion that:
1. When (i) the applicable Base Indenture and any supplemental indenture to be entered into in connection with the issuance of any Debt Security have been duly authorized, executed and delivered by the relevant trustee and the Company, (ii) the specific terms of a particular Debt Security have been duly authorized and established in accordance with the applicable Base Indenture and supplemental indenture and (iii) such Debt Security has been duly authorized, executed, authenticated, issued, delivered and paid for as contemplated by the Registration Statement and any prospectus supplement relating thereto, and in accordance with the applicable Base Indenture and supplemental indenture and the applicable underwriting or other agreement, such Debt Security will constitute a valid and binding obligation of the Company, enforceable in accordance with its terms, except to the extent that enforcement may be limited by (a) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar other laws now or hereinafter in effect relating to or affecting the enforcement of creditors’ rights generally and (b) general principles of equity (regardless of whether considered in a proceeding at law or in equity).
2. Upon (i) designation of the relative rights, preferences and limitations of any series of Preferred Stock and approval of the terms of the offering thereof and related matters by the Board of Directors in accordance with the Company’s Certificate of Incorporation and (ii) the proper filing with the Secretary of State of the State of Delaware of a Certificate of Designations relating to such series of Preferred Stock, all necessary corporate action on the part of the Company will have been taken to authorize the issuance and sale of such series of Preferred Stock proposed to be sold by the Company, and when such shares of Preferred Stock are issued, delivered and paid for as contemplated by the Registration Statement and any prospectus supplement relating thereto, and in accordance with the applicable underwriting or other agreement, such shares of Preferred Stock will be validly issued, fully paid and non-assessable.
HealthEquity, Inc.
September 9, 2021
Page 3
3. When (i) all necessary corporate action on the part of the Company has been taken to authorize the issuance and sale of such shares of Common Stock proposed to be sold by the Company under the Registration Statement and any prospectus supplement relating thereto, including upon conversion of the Debt Securities or the Preferred Stock or exercise of the Warrants, and (ii) such shares of Common Stock are issued, delivered and paid for as contemplated by the Registration Statement and any prospectus supplement relating thereto, and in accordance with the applicable underwriting or other agreement and the terms of such Debt Securities, Preferred Stock or Warrants, as applicable, such shares of Common Stock will be validly issued, fully paid and non-assessable.
4. When (i) the creation of and the issuance and terms of the Warrants, the terms of the offering thereof and related matters have been duly approved by all necessary corporate action of the Board of Directors, (ii) the warrant agreement or agreements relating to the Warrants have been duly authorized and validly executed and delivered by the Company and the warrant agent appointed by the Company and (iii) the Warrants or certificates representing the Warrants have been duly executed, authenticated, issued, delivered and paid for as contemplated by the Registration Statement and any prospectus supplement relating thereto, and in accordance with the applicable underwriting or other agreement, the Warrants will be duly authorized and validly issued and will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, except to the extent that enforcement may be limited by (a) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar other laws now or hereinafter in effect relating to or affecting the enforcement of creditors’ rights generally and (b) general principles of equity (regardless of whether considered in a proceeding at law or in equity).
5. When (i) the creation of and the issuance and terms of the Units, the terms of the offering thereof and related matters have been duly approved by all necessary corporate action of the Board of Directors, (ii) the unit agreement, if any, relating to the Units has been duly authorized and validly executed and delivered by the Company and (iii) the Units or certificates representing the Units have been duly executed, authenticated, issued and delivered against payment of the consideration fixed therefor, as contemplated by the Registration Statement and any prospectus supplement relating thereto, and in accordance with the applicable underwriting or other agreement, the Units will be duly authorized and validly issued and will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, except to the extent that enforcement may be limited by (a) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar other laws now or hereinafter in effect relating to or affecting the enforcement of creditors’ rights generally and (b) general principles of equity (regardless of whether considered in a proceeding at law or in equity).
6. The Selling Stockholder Shares are validly issued, fully paid and non-assessable.
The opinions expressed herein are limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the federal laws of the United States of America, and we express no opinion with respect to the laws of any other country, state or jurisdiction.
This opinion is limited to matters expressly set forth herein, and no opinion is to be implied or may be inferred beyond the matters expressly stated herein.
HealthEquity, Inc.
September 9, 2021
Page 4
The opinions expressed herein are given as of the date hereof, and we assume no obligation to update or supplement such opinions after the date hereof.
We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and to the use of our name under the heading “Legal Matters” in the Registration Statement and in the related prospectus or any supplemental prospectus thereto. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.
| Very truly yours, | |
| /s/ Willkie Farr & Gallagher LLP |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of HealthEquity, Inc. of our report dated March 31, 2021 relating to the financial statements, and the effectiveness of internal control over financial reporting, which appears in HealthEquity, Inc.'s Annual Report on Form 10-K for the year ended January 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
| /s/ PricewaterhouseCoopers LLP | |
| Salt Lake City, UT | |
| September 9, 2021 |
Exhibit 25.1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
| __ | CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) |
WELLS FARGO BANK, NATIONAL ASSOCIATION
(Exact name of trustee as specified in its charter)
| A National Banking Association | 94-1347393 |
|
(Jurisdiction of incorporation or |
(I.R.S. Employer |
|
101 North Phillips Avenue |
57104 |
| (Address of principal executive offices) | (Zip code) |
Wells Fargo & Company
Law Department, Trust Section
MAC N9305-175
Sixth Street and Marquette Avenue, 17th Floor
Minneapolis, Minnesota 55479
(612) 667-4608
(Name, address and telephone number of agent for service)
HEALTHEQUITY, INC.
(Exact name of obligor as specified in its charter)
| Delaware | 52-2383166 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 15 W. Scenic Pointe Dr. | ||
| Ste. 100 | ||
| Draper, Utah | 84020 | |
| (Address of principal executive offices) | (Zip code) |
Debt Securities
(Title of the indenture securities)
Item 1. General Information.
Furnish the following information as to the trustee –
(a) Name and address of each examining or supervising authority to which it is subject.
Comptroller of the Currency
Treasury Department
Washington, D.C.
Federal Deposit Insurance Corporation
Washington, D.C.
Federal Reserve Bank of San Francisco
San Francisco, California 94120
(b) Whether it is authorized to exercise corporate trust powers.
The trustee is authorized to exercise corporate trust powers.
Item 2. Affiliations with the obligor.
If the obligor is an affiliate of the trustee, describe each such affiliation.
None with respect to the trustee.
No responses are included for Items 3-14 of this Form T-1 because the obligor is not in default as provided under Item 13.
Item 15. Foreign Trustee.
Identify the order or rule pursuant to which the foreign trustee is authorized to act as sole trustee under indentures qualified under the Act.
Not applicable.
Item 16. List of exhibits.
List below all exhibits filed as a part of this Statement of Eligibility.
| Exhibit 1. | A copy of the Articles of Association of the trustee as now in effect.* |
| Exhibit 2. | A copy of the Comptroller of the Currency Certificate of Corporate Existence for Wells Fargo Bank, National Association, dated November 1, 2019.* |
| Exhibit 3. | A copy of the Comptroller of the Currency Certification of Fiduciary Powers for Wells Fargo Bank, National Association, dated November 1, 2019.* |
| Exhibit 4. | A copy of the existing bylaws of the trustee.* |
| Exhibit 5. | Not applicable. |
| Exhibit 6. | The consent of the trustee required by Section 321(b) of the Act. |
| Exhibit 7. | A copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority. |
| Exhibit 8. | Not applicable. |
| Exhibit 9. | Not applicable. |
| * | Incorporated by reference to the exhibit of the same number to the trustee’s Form T-1 filed as exhibit 25.1 to the Filing S-3ASR dated December 20, 2019 of Cboe Global Markets, Inc., file number 333-235649. |
SIGNATURE
Pursuant to the requirements of the Trust Indenture Act of 1939 the trustee, Wells Fargo Bank, National Association, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Minneapolis, and State of Minnesota, on the 3rd day of September, 2021.
|
WELLS FARGO BANK, NATIONAL ASSOCIATION | |||
| By: | /s/ Theresa M. Hempeck | ||
| Name: | Theresa M. Hempeck | ||
| Title: | Vice President | ||
EXHIBIT 6
September 3, 2021
Securities and Exchange Commission
Washington, D.C. 20549
Ladies and Gentlemen:
In accordance with Section 321(b) of the Trust Indenture Act of 1939, as amended, the undersigned hereby consents that reports of examination of the undersigned made by Federal, State, Territorial, or District authorities authorized to make such examination may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.
| Very truly yours, | |
| WELLS FARGO BANK, NATIONAL ASSOCIATION | |
| /s/ Theresa M. Hempeck | |
|
Theresa M. Hempeck |
Exhibit 7
Consolidated Report of Condition of
Wells Fargo Bank National Association
of 101 North Phillips Avenue, Sioux Falls, SD 57104
And Foreign and Domestic Subsidiaries,
at the close of business June 30, 2021, filed in accordance with 12 U.S.C. §161 for National Banks.
| Dollar Amounts | ||||||||
| In Millions | ||||||||
| ASSETS | ||||||||
| Cash and balances due from depository institutions: | ||||||||
| Noninterest-bearing balances and currency and coin | $ | 24,485 | ||||||
| Interest-bearing balances | 246,726 | |||||||
| Securities: | ||||||||
| Held-to-maturity securities | 260,942 | |||||||
| Available-for-sale securities | 179,533 | |||||||
| Equity Securities with readily determinable fair value not held for trading | 11 | |||||||
| Federal funds sold and securities purchased under agreements to resell: | ||||||||
| Federal funds sold in domestic offices | 66 | |||||||
| Securities purchased under agreements to resell | 69,654 | |||||||
| Loans and lease financing receivables: | ||||||||
| Loans and leases held for sale | 23,048 | |||||||
| Loans and leases, net of unearned income | 814,518 | |||||||
| LESS: Allowance for loan and lease losses | 14,938 | |||||||
| Loans and leases, net of unearned income and allowance | 799,580 | |||||||
| Trading Assets | 67,985 | |||||||
| Premises and fixed assets (including capitalized leases) | 10,914 | |||||||
| Other real estate owned | 148 | |||||||
| Investments in unconsolidated subsidiaries and associated companies | 13,445 | |||||||
| Direct and indirect investments in real estate ventures | 68 | |||||||
| Intangible assets | 30,685 | |||||||
| Other assets | 49,428 | |||||||
| Total assets | $ | 1,776,718 | ||||||
| LIABILITIES | ||||||||
| Deposits: | ||||||||
| In domestic offices | $ | 1,465,966 | ||||||
| Noninterest-bearing | 559,946 | |||||||
| Interest-bearing | 906,020 | |||||||
| In foreign offices, Edge and Agreement subsidiaries, and IBFs | 28,631 | |||||||
| Noninterest-bearing | 249 | |||||||
| Interest-bearing | 28,382 | |||||||
| Federal funds purchased and securities sold under agreements to repurchase: | ||||||||
| Federal funds purchased in domestic offices | 3,784 | |||||||
| Securities sold under agreements to repurchase | 5,311 | |||||||
| Dollar Amounts | ||||
| In Millions | ||||
| Trading liabilities | 13,392 | |||
| Other borrowed money | ||||
| (Includes mortgage indebtedness and obligations under capitalized leases) | 41,650 | |||
| Subordinated notes and debentures | 12,084 | |||
| Other liabilities | 33,330 | |||
| Total liabilities | $ | 1,604,148 | ||
| EQUITY CAPITAL | ||||
| Perpetual preferred stock and related surplus | 0 | |||
| Common stock | 519 | |||
| Surplus (exclude all surplus related to preferred stock) | 114,820 | |||
| Retained earnings | 55,913 | |||
| Accumulated other comprehensive income | 1,287 | |||
| Other equity capital components | 0 | |||
| Total bank equity capital | 172,539 | |||
| Noncontrolling (minority) interests in consolidated subsidiaries | 31 | |||
| Total equity capital | 172,570 | |||
| Total liabilities, and equity capital | $ | 1,776,718 | ||
I, Michael P. Santomassimo, Sr. EVP & CFO of the above-named bank do hereby declare that this Report of Condition has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true to the best of my knowledge and belief.
Michael P. Santomassimo
Sr. EVP & CFO
We, the undersigned directors, attest to the correctness of this Report of Condition and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.
Directors
Maria R. Morris
Theodore F. Craver, Jr.
Juan A. Pujadas